1834 Investment Advisors’s Repligen RGEN Stock Holding History

1834 Investment Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$19K	–	497
2020 Q4	$19K	Buy	+100	New	+$18.2K	﹤0.01%	323

Other funds holding RGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1834 Investment Advisors's RGEN Position: Q1 2021 in Review

1834 Investment Advisors sold out of Repligen (RGEN) in Q1 2021, closing a stake of 100 shares — an estimated $19K sold.

1834 Investment Advisors first reported a position in RGEN in Q4 2020 and held it in 1 quarter. The position peaked at $19K in Q4 2020. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

1834 Investment Advisors reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
1834 Investment Advisors sold 100 Repligen shares in Q1 2021, an estimated $19K.
1834 Investment Advisors first reported a position in Repligen in Q4 2020 and held it in 1 quarter.
1834 Investment Advisors's Repligen position peaked at $19K in Q4 2020.
458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on 1834 Investment Advisors's 13F filing for Q1 2021, filed 14 May 2021.